2+ hour, 45+ min ago  (73+ words) Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major depressive disorder ("MDD") and post-traumatic stress disorder ("PTSD"), today announced the initiation of its…...

3+ week, 3+ day ago  (249+ words) Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1 If approved, TEV-'749 could help address a significant unmet need in available schizophrenia treatment options by addressing the lack of viable…...

1+ mon, 1+ week ago  (367+ words) RESEARCH TRIANGLE PARK, N.C., February 09, 2026--Evecxia Therapeutics, Inc.a clinical-stage neuroscience company developing a novel class of Serotonin Synthesis Amplification therapiestoday announced that the first patient has been dosed in a Phase 1b randomized, placebo-controlled target-engagement study in patients with depression and…...

1+ mon, 3+ day ago  (209+ words) Cognitive impairment represents a core, persistent feature of schizophrenia affecting nearly all patients and is a major driver of long-term functional disability, for which there are currently no approved pharmacologic treatments. Baseline analyses from all screened participants demonstrated a statistically…...

2+ mon, 2+ day ago  (385+ words) The trial is designed to assess the accuracy, reliability, and clinical utility of the technology in real-world clinical conditions. While internal non-clinical testing has demonstrated promising performance, this study represents a critical step toward clinical validation - an essential requirement for…...

1+ mon, 3+ week ago  (190+ words) MAAC, a nonprofit offering holistic college and career readiness programs that integrate mindfulness, social and emotional wellness, and community engagement, serves thousands of high school students, including many from the country's most vulnerable communities. Through this partnership, The Limitless Foundation…...

3+ mon, 2+ week ago  (267+ words) NEW YORK, Dec. 1, 2025 /PRNewswire/ --The Steve Fund, a leading nonprofit dedicated to promoting the mental health and emotional well-being of young people from underserved and under-resourced communities, celebrates 10 years of transformative impact. Decade of Measurable Impact: 250 partner institutions and organizations…...

4+ mon, 6+ day ago  (256+ words) The Life and Times of a Connecticut Psychiatrist SOUTH WINDSOR,Conn., Nov. 10, 2025 /PRNewswire/ -- A new book by a Connecticut psychiatrist starts off this way: "On a bright day in the late 1980s, I found myself strapped into an electric chair." In…...

4+ mon, 1+ week ago  (250+ words) Ketamine treatment at Serenity helps alleviate mental health symptoms COLORADO SPRINGS, Colo., November 03, 2025--(BUSINESS WIRE)--Serenity Mental Health Centers, a leader in innovative psychiatric care and one of the fastest-growing mental health providers in the nation, today announced the expansion…...

4+ mon, 1+ week ago  (1010+ words) In pivotal trials, CAPLYTA" did not increase mean weight gain, metabolic changes, or reported sexual side effects1,2 In a six-month open-label extension safety study, safety profile was consistent with pivotal studies and 80% of MDD patients taking CAPLYTA" achieved response, with 65% of…...